logo-loader
viewTrutrace Technologies Inc.

Full interview: TruTrace Technologies ready to focus attention on generating revenue in 2020

TruTrace Technologies (CSE: TTT) CEO Robert Galarza joined Steve Darling from Proactive Vancouver with new the company the has completed their beta testing with Shoppers Drug Mart and he talks about what is next.  

Galarza also discussed turning his attention to revenue and what markets they may be looking at in Australia. 

Quick facts: Trutrace Technologies Inc.

Price: 0.075 CAD

CSE:TTT
Market: CSE
Market Cap: $6.25 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Trutrace Technologies Inc. named herein, including the promotion by the Company of Trutrace Technologies Inc. in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

TruTrace Technologies partner Shoppers Drug Mart looks to add more data to...

TruTrace Technologies (CSE: TTT-OTCQB: TTTSF) CEO Robert Galarza joined Steve Darling from Proactive Vancouver with news their partner company Shoppers Drug mart is now looking to increase available data from its online medical cannabis marketplace to try and allow doctors to access more...

on 10/7/20

2 min read